These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 22438318)
1. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers. Hristozova T; Konschak R; Budach V; Tinhofer I Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318 [TBL] [Abstract][Full Text] [Related]
2. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. Tinhofer I; Hristozova T; Stromberger C; Keilhoiz U; Budach V Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e685-90. PubMed ID: 22583603 [TBL] [Abstract][Full Text] [Related]
3. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Hristozova T; Konschak R; Stromberger C; Fusi A; Liu Z; Weichert W; Stenzinger A; Budach V; Keilholz U; Tinhofer I Ann Oncol; 2011 Aug; 22(8):1878-85. PubMed ID: 21525401 [TBL] [Abstract][Full Text] [Related]
4. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system. Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318 [TBL] [Abstract][Full Text] [Related]
5. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540 [TBL] [Abstract][Full Text] [Related]
6. Flow Cytometric Detection of Circulating Tumor Cells Using a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR). Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y Methods Mol Biol; 2017; 1634():211-217. PubMed ID: 28819854 [TBL] [Abstract][Full Text] [Related]
7. Enumeration of Circulating Tumor Cells and Disseminated Tumor Cells in Blood and Bone Marrow by Immunomagnetic Enrichment and Flow Cytometry (IE/FC). Magbanua MJM; Solanki TI; Ordonez AD; Hsiao F; Park JW Methods Mol Biol; 2017; 1634():203-210. PubMed ID: 28819853 [TBL] [Abstract][Full Text] [Related]
9. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells. Lin HC; Hsu HC; Hsieh CH; Wang HM; Huang CY; Wu MH; Tseng CP Clin Chim Acta; 2013 Apr; 419():77-84. PubMed ID: 23415697 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients. Lustberg MB; Balasubramanian P; Miller B; Garcia-Villa A; Deighan C; Wu Y; Carothers S; Berger M; Ramaswamy B; Macrae ER; Wesolowski R; Layman RM; Mrozek E; Pan X; Summers TA; Shapiro CL; Chalmers JJ Breast Cancer Res; 2014 Mar; 16(2):R23. PubMed ID: 24602188 [TBL] [Abstract][Full Text] [Related]
11. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test. Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318 [TBL] [Abstract][Full Text] [Related]
12. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U J Transl Med; 2011 May; 9():70. PubMed ID: 21595914 [TBL] [Abstract][Full Text] [Related]
13. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low. Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851 [TBL] [Abstract][Full Text] [Related]
14. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy. Jia M; Mao Y; Wu C; Wang S; Zhang H Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702 [TBL] [Abstract][Full Text] [Related]
15. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma. Tada H; Takahashi H; Kawabata-Iwakawa R; Nagata Y; Uchida M; Shino M; Ida S; Mito I; Matsuyama T; Chikamatsu K Sci Rep; 2020 Dec; 10(1):21573. PubMed ID: 33299117 [TBL] [Abstract][Full Text] [Related]
16. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508 [TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation. Kawada T; Takahashi H; Sakakura K; Ida S; Mito I; Toyoda M; Chikamatsu K Head Neck; 2017 Nov; 39(11):2180-2186. PubMed ID: 28815839 [TBL] [Abstract][Full Text] [Related]
18. Multispectral Imaging Analysis of Circulating Tumor Cells in Negatively Enriched Peripheral Blood Samples. Miller B; Lustberg M; Summers TA; Chalmers JJ Methods Mol Biol; 2017; 1634():219-234. PubMed ID: 28819855 [TBL] [Abstract][Full Text] [Related]
20. Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology. Jatana KR; Balasubramanian P; McMullen KP; Lang JC; Teknos TN; Chalmers JJ Head Neck; 2016 Dec; 38(12):1799-1803. PubMed ID: 27265898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]